Cinemark (NYSE:CNK) PT Lowered to $43.00 at MKM Partners
Cinemark (NYSE:CNK) had its price objective trimmed by MKM Partners to $43.00 in a research note published on Monday, The Fly reports. The firm currently has a buy rating on the stock.
A number of other equities research analysts also recently commented on CNK. ValuEngine upgraded Zynerba Pharmaceuticals from a sell rating to a hold rating in a report on Monday, April 1st. Loop Capital reiterated a hold rating on shares of AMC Entertainment in a report on Wednesday, July 3rd. Finally, Wedbush set a $13.00 price objective on SLM and gave the company a buy rating in a report on Monday, April 22nd. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Cinemark has a consensus rating of Buy and a consensus price target of $44.56.
NYSE CNK opened at $37.78 on Monday. The firm has a 50-day moving average of $37.41. The company has a market capitalization of $4.46 billion, a P/E ratio of 20.64, a PEG ratio of 1.09 and a beta of 0.73. The company has a quick ratio of 0.80, a current ratio of 0.83 and a debt-to-equity ratio of 2.18. Cinemark has a 12 month low of $34.03 and a 12 month high of $43.51.
The firm also recently declared a quarterly dividend, which was paid on Monday, June 24th. Shareholders of record on Monday, June 10th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $1.36 annualized dividend and a dividend yield of 3.60%. Cinemark’s dividend payout ratio (DPR) is currently 74.32%.
In other Cinemark news, insider Valmir Fernandes sold 4,033 shares of the stock in a transaction dated Tuesday, May 7th. The stock was sold at an average price of $43.00, for a total value of $173,419.00. Following the completion of the sale, the insider now directly owns 114,961 shares in the company, valued at $4,943,323. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 9.00% of the stock is owned by corporate insiders.
Several institutional investors have recently made changes to their positions in CNK. Norges Bank bought a new stake in shares of Cinemark in the fourth quarter worth about $36,407,000. Clark Capital Management Group Inc. increased its holdings in shares of Cinemark by 162.8% in the first quarter. Clark Capital Management Group Inc. now owns 1,162,491 shares of the company’s stock worth $46,488,000 after acquiring an additional 720,110 shares in the last quarter. DNB Asset Management AS bought a new stake in shares of Cinemark in the second quarter worth about $25,830,000. Eagle Asset Management Inc. boosted its position in shares of Cinemark by 21.7% during the first quarter. Eagle Asset Management Inc. now owns 3,185,009 shares of the company’s stock worth $127,368,000 after buying an additional 566,923 shares during the period. Finally, Wells Fargo & Company MN boosted its position in shares of Cinemark by 34.6% during the first quarter. Wells Fargo & Company MN now owns 1,962,955 shares of the company’s stock worth $78,498,000 after buying an additional 504,333 shares during the period. Institutional investors own 98.67% of the company’s stock.
Cinemark Company Profile
Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of December 31, 2018, it operated 341 theatres and 4,586 screens in 41 states of the United States; and 205 theatres and 1,462 screens in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao, and Paraguay.
Featured Story: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.